제세동기 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The Defibrillator Market report provides a detailed analysis of the industry, covering key dynamics, growth factors, challenges, and emerging trends for the period from 2024 to 2032. This report offers insights into the current scenario and future projections of the global defibrillator market.

The global defibrillator market is projected to grow at a compound annual growth rate (CAGR) of 7.4% from USD 12.2 billion in 2024 to USD 24.9 billion by 2032.

Key Insights:

• Estimated Market Size (2024): USD 12.2 Billion
• Projected Market Size (2032): USD 24.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 7.4%

Defibrillator Market - Report Scope:

Defibrillators are critical medical devices used in the treatment of sudden cardiac arrest (SCA). They deliver a therapeutic dose of electrical energy to the affected heart. The report outlines key drivers of demand for defibrillators, including increasing incidence of cardiovascular diseases, growing public awareness about the importance of early defibrillation in saving lives, and advancements in defibrillator technology.

Market Growth Drivers:

Several factors contribute to the growth of the defibrillator market. The primary driver is the rising prevalence of cardiovascular diseases globally, which increases the risk of sudden cardiac arrest. Additionally, the expansion of public access defibrillation programs, which involve placing automated external defibrillators (AEDs) in public spaces like airports, schools, and sports arenas, is another significant growth driver. Technological advancements in defibrillators, making them more user-friendly and effective, also support market expansion. Furthermore, government initiatives to train non-medical personnel in the use of AEDs and the implementation of stringent regulations mandating the availability of defibrillators in public places enhance market growth.

Market Restraints:

Despite the positive outlook, the defibrillator market faces challenges. High costs associated with advanced defibrillator systems can hinder market growth, particularly in underdeveloped and developing regions. Also, issues related to the maintenance and replacement of these devices pose additional challenges. Regulatory hurdles for approval and concerns about device malfunction or failure can also impede market growth.

Market Opportunities:

The defibrillator market offers significant opportunities for growth and innovation. One major opportunity lies in the development of more sophisticated implantable cardioverter defibrillators (ICDs) and wearable defibrillator devices that can better cater to patient needs. Expanding the reach of AEDs into rural and underserved areas presents another growth avenue. Additionally, increasing collaborations between public organizations and private companies to enhance public awareness and training programs can further expand the market.

Key Questions Addressed in the Report:

• What is the Expected CAGR of the Global Defibrillator Market from 2024 to 2032?
• What are the Key Factors Driving the Growth of the Defibrillator Market?
• Which Product Type Holds the Largest Market Share in the Defibrillator Market?
• Who are the Key Players in the Global Defibrillator Market?
• What Strategies are Adopted by Leading Companies to Stay Competitive in the Defibrillator Market?

Competitive Landscape and Business Strategies:

The key players in the Defibrillator Market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V., and ZOLL Medical Corporation, among others. These companies focus on innovation, such as integrating advanced monitoring technologies with defibrillators, to maintain their market position. Strategic partnerships and acquisitions are also commonly pursued to expand product lines and geographic presence.

Key Companies Profiled

• Medtronic
• Abbott
• Boston Scientific Corporation
• Stryker
• Zoll Medical Corporation
• Biotronik
• Nihon Kohden Corporation
• METRAWATT International
• Datrend Systems
• Fluke
• BC Group International
• Netech

Market Segments Covered in Defibrillator Market Analysis

By Component

• Implantable Cardioverter Defibrillators (ICD)
• External Defibrillators (ED)

By Type

• S-ICD
• T-ICD
• Manual ED
• Automated ED
• Wearable Cardioverter Defibrillators

By End Use

• Hospital
• Pre Hospital
• Public Access Market
• Alternate Care Market
• Home Healthcare

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Product Life Cycle Analysis
• 3.5. Supply Chain Analysis
  • 3.5.1. Supply Side Participants and their Roles
    • 3.5.1.1. Producers
  • 3.5.2. Value Added and Value Created at Node in the Supply Chain
  • 3.5.3. List of Existing and Potential Buyer's
• 3.6. Investment Feasibility Matrix
• 3.7. Value Chain Analysis
  • 3.7.1. Profit Margin Analysis
• 3.8. PESTLE and Porter's Analysis
• 3.9. Regulatory Landscape
  • 3.9.1. By Key Regions
  • 3.9.2. By Key Countries
• 3.10. Regional Parent Market Outlook
• 3.11. Production and Consumption Statistics
• 3.12. Import and Export Statistics

4. Global Defibrillator Market Analysis 2019-2023 and Forecast, 2024-2032

• 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2032
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2024-2032
  • 5.3.1. Implantable Cardioverter Defibrillators (ICD)
    • 5.3.1.1. S-ICD
    • 5.3.1.2. T-ICD
  • 5.3.2. External Defibrillators (ED)
    • 5.3.2.1. Manual ED
    • 5.3.2.2. Automated ED
    • 5.3.2.3. Wearable Cardioverter Defibrillators
• 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2024-2032
  • 6.3.1. Hospital
  • 6.3.2. Pre Hospital
  • 6.3.3. Public Access Market
  • 6.3.4. Alternate Care Market
  • 6.3.5. Home Healthcare
• 6.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By End User, 2024-2032

7. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 7.1. Introduction
• 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
• 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2032
  • 7.3.1. North America
  • 7.3.2. Latin America
  • 7.3.3. Europe
  • 7.3.4. East Asia
  • 7.3.5. South Asia
  • 7.3.6. Oceania
  • 7.3.7. MEA
• 7.4. Market Attractiveness Analysis By Region

8. North America Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 8.2.1. By Country
    • 8.2.1.1. U.S.
    • 8.2.1.2. Canada
  • 8.2.2. By Product Type
  • 8.2.3. By End User
• 8.3. Market Attractiveness Analysis
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By End User
• 8.4. Key Takeaways

9. Latin America Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 9.2.1. By Country
    • 9.2.1.1. Brazil
    • 9.2.1.2. Mexico
    • 9.2.1.3. Argentina
    • 9.2.1.4. Rest of Latin America
  • 9.2.2. By Product Type
  • 9.2.3. By End User
• 9.3. Market Attractiveness Analysis
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By End User
• 9.4. Key Takeaways

10. Europe Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 10.2.1. By Country
    • 10.2.1.1. Germany
    • 10.2.1.2. Italy
    • 10.2.1.3. France
    • 10.2.1.4. U.K.
    • 10.2.1.5. Spain
    • 10.2.1.6. Russia
    • 10.2.1.7. BENELUX
    • 10.2.1.8. Rest of Europe
  • 10.2.2. By Product Type
  • 10.2.3. By End User
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By End User
• 10.4. Key Takeaways

11. East Asia Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 11.2.1. By Country
    • 11.2.1.1. China
    • 11.2.1.2. Japan
    • 11.2.1.3. South Korea
  • 11.2.2. By Product Type
  • 11.2.3. By End User
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Product Type
  • 11.3.3. By End User
• 11.4. Key Takeaways

12. South Asia Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 12.2.1. By Country
    • 12.2.1.1. India
    • 12.2.1.2. Thailand
    • 12.2.1.3. Malaysia
    • 12.2.1.4. Indonesia
    • 12.2.1.5. Rest of South Asia
  • 12.2.2. By Product Type
  • 12.2.3. By End User
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Product Type
  • 12.3.3. By End User
• 12.4. Key Takeaways

13. Oceania Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 13.2.1. By Country
    • 13.2.1.1. Australia
    • 13.2.1.2. New Zealand
  • 13.2.2. By Product Type
  • 13.2.3. By End User
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Product Type
  • 13.3.3. By End User
• 13.4. Key Takeaways

14. MEA Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 14.2.1. By Country
    • 14.2.1.1. GCC
    • 14.2.1.2. Rest of MEA
  • 14.2.2. By Product Type
  • 14.2.3. By End User
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Product Type
  • 14.3.3. By End User
• 14.4. Key Takeaways

15. Key Countries Defibrillator Market Analysis

• 15.1. U.S.
  • 15.1.1. Pricing Analysis
  • 15.1.2. Market Share Analysis, 2024
    • 15.1.2.1. By Product Type
    • 15.1.2.2. By End User
• 15.2. Canada
  • 15.2.1. Pricing Analysis
  • 15.2.2. Market Share Analysis, 2024
    • 15.2.2.1. By Product Type
    • 15.2.2.2. By End User
• 15.3. Brazil
  • 15.3.1. Pricing Analysis
  • 15.3.2. Market Share Analysis, 2024
    • 15.3.2.1. By Product Type
    • 15.3.2.2. By End User
• 15.4. Mexico
  • 15.4.1. Pricing Analysis
  • 15.4.2. Market Share Analysis, 2024
    • 15.4.2.1. By Product Type
    • 15.4.2.2. By End User
• 15.5. Argentina
  • 15.5.1. Pricing Analysis
  • 15.5.2. Market Share Analysis, 2024
    • 15.5.2.1. By Product Type
    • 15.5.2.2. By End User
• 15.6. Germany
  • 15.6.1. Pricing Analysis
  • 15.6.2. Market Share Analysis, 2024
    • 15.6.2.1. By Product Type
    • 15.6.2.2. By End User
• 15.7. Italy
  • 15.7.1. Pricing Analysis
  • 15.7.2. Market Share Analysis, 2024
    • 15.7.2.1. By Product Type
    • 15.7.2.2. By End User
• 15.8. France
  • 15.8.1. Pricing Analysis
  • 15.8.2. Market Share Analysis, 2024
    • 15.8.2.1. By Product Type
    • 15.8.2.2. By End User
• 15.9. U.K.
  • 15.9.1. Pricing Analysis
  • 15.9.2. Market Share Analysis, 2024
    • 15.9.2.1. By Product Type
    • 15.9.2.2. By End User
• 15.10. Spain
  • 15.10.1. Pricing Analysis
  • 15.10.2. Market Share Analysis, 2024
    • 15.10.2.1. By Product Type
    • 15.10.2.2. By End User
• 15.11. Russia
  • 15.11.1. Pricing Analysis
  • 15.11.2. Market Share Analysis, 2024
    • 15.11.2.1. By Product Type
    • 15.11.2.2. By End User
• 15.12. BENELUX
  • 15.12.1. Pricing Analysis
  • 15.12.2. Market Share Analysis, 2024
    • 15.12.2.1. By Product Type
    • 15.12.2.2. By End User
• 15.13. China
  • 15.13.1. Pricing Analysis
  • 15.13.2. Market Share Analysis, 2024
    • 15.13.2.1. By Product Type
    • 15.13.2.2. By End User
• 15.14. Japan
  • 15.14.1. Pricing Analysis
  • 15.14.2. Market Share Analysis, 2024
    • 15.14.2.1. By Product Type
    • 15.14.2.2. By End User
• 15.15. South Korea
  • 15.15.1. Pricing Analysis
  • 15.15.2. Market Share Analysis, 2024
    • 15.15.2.1. By Product Type
    • 15.15.2.2. By End User
• 15.16. India
  • 15.16.1. Pricing Analysis
  • 15.16.2. Market Share Analysis, 2024
    • 15.16.2.1. By Product Type
    • 15.16.2.2. By End User
• 15.17. Thailand
  • 15.17.1. Pricing Analysis
  • 15.17.2. Market Share Analysis, 2024
    • 15.17.2.1. By Product Type
    • 15.17.2.2. By End User
• 15.18. Malaysia
  • 15.18.1. Pricing Analysis
  • 15.18.2. Market Share Analysis, 2024
    • 15.18.2.1. By Product Type
    • 15.18.2.2. By End User
• 15.19. Indonesia
  • 15.19.1. Pricing Analysis
  • 15.19.2. Market Share Analysis, 2024
    • 15.19.2.1. By Product Type
    • 15.19.2.2. By End User
• 15.20. Australia
  • 15.20.1. Pricing Analysis
  • 15.20.2. Market Share Analysis, 2024
    • 15.20.2.1. By Product Type
    • 15.20.2.2. By End User
• 15.21. New Zealand
  • 15.21.1. Pricing Analysis
  • 15.21.2. Market Share Analysis, 2024
    • 15.21.2.1. By Product Type
    • 15.21.2.2. By End User
• 15.22. GCC Countries
  • 15.22.1. Pricing Analysis
  • 15.22.2. Market Share Analysis, 2024
    • 15.22.2.1. By Product Type
    • 15.22.2.2. By End User

16. Market Structure Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Benchmarking
• 16.3. Market Share Analysis of Top Players
  • 16.3.1. By Regional
  • 16.3.2. By Product Type
  • 16.3.3. By End User

17. Competition Analysis

• 17.1. Competition Deep Dive
  • 17.1.1. Medtronic
    • 17.1.1.1. Overview
    • 17.1.1.2. Product Portfolio
    • 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.1.4. Sales Footprint
    • 17.1.1.5. Strategy Overview
      • 17.1.1.5.1. Marketing Strategy
      • 17.1.1.5.2. Product Strategy
      • 17.1.1.5.3. Channel Strategy
  • 17.1.2. Abbott
    • 17.1.2.1. Overview
    • 17.1.2.2. Product Portfolio
    • 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.2.4. Sales Footprint
    • 17.1.2.5. Strategy Overview
      • 17.1.2.5.1. Marketing Strategy
      • 17.1.2.5.2. Product Strategy
      • 17.1.2.5.3. Channel Strategy
  • 17.1.3. Boston Scientific Corporation
    • 17.1.3.1. Overview
    • 17.1.3.2. Product Portfolio
    • 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.3.4. Sales Footprint
    • 17.1.3.5. Strategy Overview
      • 17.1.3.5.1. Marketing Strategy
      • 17.1.3.5.2. Product Strategy
      • 17.1.3.5.3. Channel Strategy
  • 17.1.4. Stryker
    • 17.1.4.1. Overview
    • 17.1.4.2. Product Portfolio
    • 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.4.4. Sales Footprint
    • 17.1.4.5. Strategy Overview
      • 17.1.4.5.1. Marketing Strategy
      • 17.1.4.5.2. Product Strategy
      • 17.1.4.5.3. Channel Strategy
  • 17.1.5. Zoll Medical Corporation
    • 17.1.5.1. Overview
    • 17.1.5.2. Product Portfolio
    • 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.5.4. Sales Footprint
    • 17.1.5.5. Strategy Overview
      • 17.1.5.5.1. Marketing Strategy
      • 17.1.5.5.2. Product Strategy
      • 17.1.5.5.3. Channel Strategy
  • 17.1.6. Biotronik
    • 17.1.6.1. Overview
    • 17.1.6.2. Product Portfolio
    • 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.6.4. Sales Footprint
    • 17.1.6.5. Strategy Overview
      • 17.1.6.5.1. Marketing Strategy
      • 17.1.6.5.2. Product Strategy
      • 17.1.6.5.3. Channel Strategy
  • 17.1.7. Nihon Kohden Corporation
    • 17.1.7.1. Overview
    • 17.1.7.2. Product Portfolio
    • 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.7.4. Sales Footprint
    • 17.1.7.5. Strategy Overview
      • 17.1.7.5.1. Marketing Strategy
      • 17.1.7.5.2. Product Strategy
      • 17.1.7.5.3. Channel Strategy
  • 17.1.8. METRAWATT International
    • 17.1.8.1. Overview
    • 17.1.8.2. Product Portfolio
    • 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.8.4. Sales Footprint
    • 17.1.8.5. Strategy Overview
      • 17.1.8.5.1. Marketing Strategy
      • 17.1.8.5.2. Product Strategy
      • 17.1.8.5.3. Channel Strategy
  • 17.1.9. Datrend Systems
    • 17.1.9.1. Overview
    • 17.1.9.2. Product Portfolio
    • 17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.9.4. Sales Footprint
    • 17.1.9.5. Strategy Overview
      • 17.1.9.5.1. Marketing Strategy
      • 17.1.9.5.2. Product Strategy
      • 17.1.9.5.3. Channel Strategy
  • 17.1.10. Fluke
    • 17.1.10.1. Overview
    • 17.1.10.2. Product Portfolio
    • 17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.10.4. Sales Footprint
    • 17.1.10.5. Strategy Overview
      • 17.1.10.5.1. Marketing Strategy
      • 17.1.10.5.2. Product Strategy
      • 17.1.10.5.3. Channel Strategy
  • 17.1.11. BC Group International
    • 17.1.11.1. Overview
    • 17.1.11.2. Product Portfolio
    • 17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.11.4. Sales Footprint
    • 17.1.11.5. Strategy Overview
      • 17.1.11.5.1. Marketing Strategy
      • 17.1.11.5.2. Product Strategy
      • 17.1.11.5.3. Channel Strategy
  • 17.1.12. Netech
    • 17.1.12.1. Overview
    • 17.1.12.2. Product Portfolio
    • 17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.12.4. Sales Footprint
    • 17.1.12.5. Strategy Overview
      • 17.1.12.5.1. Marketing Strategy
      • 17.1.12.5.2. Product Strategy
      • 17.1.12.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology